Multicenter randomized phase II study of short course FOLFOX + nivolumab (Nivo) followed by maintenance Nivo +/- radiation (RT) in the first line treatment of metastatic or unresectable gastroesophageal adenocarcinoma (mGEA).

Category Primary study
JournalJ. Clin. Oncol.
Year 2024
This article has no abstract
Epistemonikos ID: fa2afc4387ab29d7a8275fc44151704586694509
First added on: Jan 10, 2026